MicroRNAs参与人肺移植后基因表达失调
MicroRNAs Implicated in Dysregulation of Gene Expression Following Human Lung Transplantation
摘要:
肺移植仍然是大多数晚期肺部疾病患者唯一可行的治疗选择。然而,移植后5年存活率仍然很低,主要是继发于慢性排斥反应。全球基因表达谱的新见解可能提供分子表型和治疗靶点,以改善肺移植后的结局。我们发现,在肺移植后患者的PBMC中存在大量失调基因,特别是参与免疫反应和防御等途径和生物学过程的基因。还证明了miRNA在调节这些差异基因中的贡献。
英文摘要:
Lung transplantation remains the only viable treatment option for the majority of patients with advanced lung diseases. However, 5-year post-transplant survival rates remain low primarily secondary to chronic rejection. Novel insights from global gene expression profiles may provide molecular phenotypes and therapeutic targets to improve outcomes after lung transplantation. We showed the presence of a significant number of dysregulated genes, particularly those genes involved in pathways and biological processes such as immune response and defense, in the PBMCs derived from a cohort of patients after lung transplantation. The contribution of miRNAs in regulating these differential genes was also demonstrated.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。